生物过程
生物转化
大肠杆菌
重组DNA
生产过剩
酶
生化工程
生物制药
生物
蛋白质工程
催化效率
合成生物学
生物转化
蛋白质表达
生物化学
生物技术
计算生物学
发酵
基因
古生物学
工程类
作者
Fatemeh Poureini,Valiollah Babaeipour,Reza H. Sajedi,Rasoul Khalilzadeh
摘要
ABSTRACT The use of whole cells represents a modern approach to enzymatic bioconversion for the production of various compounds, particularly pharmaceuticals. In recent decades, the use of wild strains as whole‐cell biocatalysts has faced limitations due to challenges such as the lack of control over enzyme production and activity, as well as inefficiencies in enzyme production. As a result, recombinant cells are often employed. Among these, Escherichia coli is the most widely preferred bacterial host for producing recombinant proteins, thanks to its rapid growth, well‐developed molecular manipulation tools, the ability to achieve high cell density using cost‐effective culture components, and desirable genetic stability. The surface expression of enzymes is one of the most appropriate ways to increase the biotransformation efficiency by recombinant E. coli and reduce overall production costs due to the elimination of the need to purify enzymes and perform the enzyme conversion process in the presence of the pure substrate dissolved in the buffer. This article provides a thorough review of the various factors that influence the production of recombinant surface proteins. It examines aspects that affect biomass growth and methods to enhance protein expression. Additionally, recent research achievements in increasing the production of surface proteins are highlighted, along with promising insights that could pave the way for more sustainable and efficient approaches to producing surface‐expressed proteins.
科研通智能强力驱动
Strongly Powered by AbleSci AI